Correlation Between Estrella Immunopharma and Barratt Developments

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Barratt Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Barratt Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and Barratt Developments plc, you can compare the effects of market volatilities on Estrella Immunopharma and Barratt Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Barratt Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Barratt Developments.

Diversification Opportunities for Estrella Immunopharma and Barratt Developments

-0.58

Correlation Coefficient

Estrella Immunopharma  Barratt Developments

Excellent diversification

The 3 months correlation between Estrella and Barratt is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Barratt Developments plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Barratt Developments plc and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Barratt Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Barratt Developments plc has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Barratt Developments go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Barratt Developments

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 44.03 times more return on investment than Barratt Developments. However, Estrella Immunopharma is 44.03 times more volatile than Barratt Developments plc. It trades about 0.14 of its potential returns per unit of risk. Barratt Developments plc is currently generating about -0.23 per unit of risk. If you would invest  10.00  in Estrella Immunopharma on September 3, 2024 and sell it today you would lose (0.90) from holding Estrella Immunopharma or give up 9.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	32.81%
Values	Daily Returns

Estrella Immunopharma  vs.  Barratt Developments plc

Estrella Immunopharma

Risk-Adjusted Performance

0 of 100

OK

Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Barratt Developments plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Barratt Developments plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Estrella Immunopharma and Barratt Developments

The main advantage of trading using opposite Estrella Immunopharma and Barratt Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Barratt Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Barratt Developments will offset losses from the drop in Barratt Developments' long position.

The idea behind Estrella Immunopharma and Barratt Developments plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.